Global Biotechnology Âé¶¹Ô´´ Summary, Competitive Analysis and Forecast to 2027
Summary
Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The global biotechnology market had total revenues of $922.2 billion in 2022, representing a compound annual growth rate (CAGR) of 13.1% between 2017 and 2022.
- Medical/healthcare segment accounted for market's the largest proportion in 2022, with total revenues of $606.0 billion, equivalent to 65.7% of the market's overall value.
- The US held the largest share in the global biotechnology market, accounting for 42.9% share in 2022. The market is growing as a result of factors such as supportive government policies, the introduction of new and cutting-edge products, significant investment in the biotechnology industry, and rising demand for new and innovative goods.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global biotechnology market
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Global biotechnology market by value in 2022?
- What will be the size of the Global biotechnology market in 2027?
- What factors are affecting the strength of competition in the Global biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in the global's biotechnology market?
Table of Contents
1 Executive Summary
1.1. Âé¶¹Ô´´ value
1.2. Âé¶¹Ô´´ value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Âé¶¹Ô´´ rivalry
1.6. Competitive landscape
2 Âé¶¹Ô´´ Overview
2.1. Âé¶¹Ô´´ definition
2.2. Âé¶¹Ô´´ analysis
3 Âé¶¹Ô´´ Data
3.1. Âé¶¹Ô´´ value
4 Âé¶¹Ô´´ Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Âé¶¹Ô´´ Outlook
5.1. Âé¶¹Ô´´ value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Has there been any recent M&A activity in the market?
8 Company Profiles
8.1. Johnson & Johnson
8.2. Novartis AG
8.3. Bayer AG
8.4. Takeda Pharmaceutical Company Limited
8.5. BioNTech SE
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related Âé¶¹Ô´´Line research
10.4. About Âé¶¹Ô´´Line
List of Tables
List of Tables
Table 1: Global biotechnology industry value: $ billion, 2017–22
Table 2: Global biotechnology industry category segmentation: % share, by value, 2017–2022
Table 3: Global biotechnology industry category segmentation: $ billion, 2017-2022
Table 4: Global biotechnology industry geography segmentation: $ billion, 2022
Table 5: Global biotechnology industry value forecast: $ billion, 2022–27
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: Novartis AG: key facts
Table 11: Novartis AG: Annual Financial Ratios
Table 12: Novartis AG: Key Employees
Table 13: Novartis AG: Key Employees Continued
Table 14: Bayer AG: key facts
Table 15: Bayer AG: Annual Financial Ratios
Table 16: Bayer AG: Key Employees
Table 17: Bayer AG: Key Employees Continued
Table 18: Takeda Pharmaceutical Company Limited: key facts
Table 19: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 20: Takeda Pharmaceutical Company Limited: Key Employees
Table 21: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 22: BioNTech SE: key facts
Table 23: BioNTech SE: Annual Financial Ratios
Table 24: BioNTech SE: Key Employees
Table 25: Global exchange rate, 2018–22
List of Figures
List of Figures
Figure 1: Global biotechnology industry value: $ billion, 2017–22
Figure 2: Global biotechnology industry category segmentation: $ billion, 2017-2022
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2022
Figure 4: Global biotechnology industry value forecast: $ billion, 2022–27
Figure 5: Forces driving competition in the global biotechnology industry, 2022
Figure 6: Drivers of buyer power in the global biotechnology industry, 2022
Figure 7: Drivers of supplier power in the global biotechnology industry, 2022
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2022
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2022
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2022
Johnson & Johnson
Novartis AG
Bayer AG
Takeda Pharmaceutical Company Limited
BioNTech SE
Ìý
Ìý
*If Applicable.